saccharolactone has been researched along with Benign Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hanausek, M; Kiliańska, ZM; Walaszek, Z; Zółtaszek, R | 1 |
| Hanausek, M; Kowalczyk, MC; Kowalczyk, P; Narog, M; Slaga, TJ; Spears, E; Walaszek, Z; Yoshimi, N; Zoltaszek, R | 1 |
| BOYLAND, E; WALLACE, DM | 1 |
1 review(s) available for saccharolactone and Benign Neoplasms
| Article | Year |
|---|---|
[The biological role of D-glucaric acid and its derivatives: potential use in medicine].
Topics: Animals; Apoptosis; Glucaric Acid; Glucuronidase; Humans; Neoplasms; Oxidative Stress; Risk Factors | 2008 |
2 other study(ies) available for saccharolactone and Benign Neoplasms
| Article | Year |
|---|---|
Modulation of biomarkers related to tumor initiation and promotion in mouse skin by a natural β-glucuronidase inhibitor and its precursors.
Topics: 8-Hydroxy-2'-Deoxyguanosine; 9,10-Dimethyl-1,2-benzanthracene; Administration, Oral; Administration, Topical; Animals; Anticarcinogenic Agents; Biomarkers; Carcinogens; Deoxyguanosine; Dermatitis, Contact; Female; Glucaric Acid; Glucuronates; Glucuronidase; HSP90 Heat-Shock Proteins; Hyperplasia; Inflammation Mediators; Interleukin-1alpha; Leukocyte Count; Mice; Mice, Inbred SENCAR; Neoplasms; Skin | 2011 |
Enzyme activity in relation to cancer: inhibition of urinary beta-glucuronidase of patients with cancer of the bladder by oral administration of 1:4-saccharolactone and related compounds.
Topics: Administration, Oral; Glucaric Acid; Glucose; Glucuronidase; Humans; Neoplasms; Urinary Bladder Neoplasms | 1957 |